Back to top

Merck & Co New: (MRK)

(Delayed quote from: NYSE) As of Aug 29, 2014 04:01 PM ET

 Add to portfolio

 ZacksTrade Now

$60.11 USD

60.11

+0.11 (0.18%)

Volume: 5,715,779

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

General Information

MERCK & CO INC

ONE MERCK DRIVE P.O. BOX 100

WHITEHOUSE STATION, NJ 08889-0100

Phone: 908-423-4840

Fax: 908-735-1253

Web: http://www.merck.com

Email: NA

Industry LARGE CAP PHARMA
Sector Medical
Fiscal Year End December
Last Reported Quarter 6/30/2014
Next EPS Date 10/27/2014

EPS Information

Current Quarter EPS Consensus Estimate 0.88
Current Year EPS Consensus Estimate 3.49
Estimated Long-Term EPS Growth Rate 4.50
Next EPS Report Date 10/27/2014

Price and Volume Information

Zacks Rank
Yesterday's Close 60.00
52 Week High 60.58
52 Week Low 44.62
Beta 0.42
20 Day Moving Average 7,879,106.50
Target Price Consensus 60.67

MRK

% Price Change
4 Week 5.94
12 Week 3.46
YTD 19.88
% Price Change Relative to S&P 500
4 Week 2.09
12 Week 0.21
YTD 10.97
Share Information
Shares Outstanding (millions) 2,922.38
Market Capitalization (millions) 175,664.02
Short Ratio 4.10
Last Split Date 2/17/1999
Dividend Information
Dividend Yield 2.93%
Annual Dividend $1.76
Payout Ratio 0.50
Change in Payout Ratio 0.04
Last Dividend Payout / Amount 6/12/2014 / $0.44

Fundamental Ratios

P/E
P/E (F1) 17.19
Trailing 12 Months 17.03
PEG Ratio 3.80
EPS Growth
vs. Previous Year 1.19%
vs. Previous Quarter -3.41%
   
Sales Growth
vs. Previous Year -0.69%
vs. Previous Quarter 6.53%
   
Price Ratios
Price/Book 3.62
Price/Cash Flow 10.08
Price / Sales 4.03
ROE
6/30/14 20.49
3/31/14 20.41
12/31/13 20.08
ROA
6/30/14 9.96
3/31/14 9.79
12/31/13 9.83
Current Ratio
6/30/14 1.87
3/31/14 1.84
12/31/13 2.00
Quick Ratio
6/30/14 1.53
3/31/14 1.55
12/31/13 1.65
Operating Margin
6/30/14 23.93
3/31/14 23.98
12/31/13 23.72
Net Margin
6/30/14 12.89
3/31/14 10.35
12/31/13 10.00
Pre-Tax Margin
6/30/14 15.46
3/31/14 13.95
12/31/13 12.59
Book Value
6/30/14 16.60
3/31/14 17.88
12/31/13 17.91
Inventory Turnover
6/30/14 2.75
3/31/14 2.59
12/31/13 2.56
Debt-to-Equity
6/30/14 0.38
3/31/14 0.37
12/31/13 0.39
Debt to Capital
6/30/14 27.70
3/31/14 27.15
12/31/13 28.19